FDA Inspection 1005192 — Grifols Biomat USA, Inc.
The FDA completed an inspection of Grifols Biomat USA, Inc. on Mar 15, 2017 in Provo, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 15, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Provo, UT (United States)